Alembic Pharmaceuticals Limited (APLLTD.NS) NSE

938.60

+5.2(+0.56%)

Updated at October 17 03:30PM

Currency In INR

Valuation

Market Cap176.29B
Enterprise Value187.97B
P/E Ratio30.61
PEG Ratio8.98
Price/Sales Ratio2.7
Price/Book Ratio3.56
Enterprise/Revenue2.7
Enterprise/EBITDA16.78

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.09
Operating Margin0.21

Management Effectiveness

Return On Assets0
Return On Equity0.12

Income Statement

Revenue66.72B
Revenue/Share346.84
Gross Profit47.91B
EBITDA9.89B
Net Income5.83B
Diluted EPS29.68

Balance Sheet

Total Cash834.8M
Total Cash/Share0
Total Debt0
Total Debt/Equity0
Current Ratio0
Book Value Per Share263.88

Price History

52-Week Change-17.72
52-Week High1,188
52-Week Low725.2
Moving Average 50 Days942.38
Moving Average 200 Days927.61

Statistics

Average Volume96,271
Shares Outstanding196.56M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate11
Trailing Annual Dividend Yield1.17
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A